View in EDS HTML Full Text PDF Full Text

CAR T cells produced in vivo to treat cardiac injury.

Saved in:
Bibliographic Details
Title: CAR T cells produced in vivo to treat cardiac injury.
Authors: Rurik, Joel G., Tombácz, István, Yadegari, Amir, Fernández, Pedro O. Méndez, Shewale, Swapnil V., Li, Li, Kimura, Toru, Soliman, Ousamah Younoss, Papp, Tyler E., Tam, Ying K., Mui, Barbara L., Albelda, Steven M., Puré, Ellen, June, Carl H., Aghajanian, Haig, Weissman, Drew, Parhiz, Hamideh, Epstein, Jonathan A.
Source: Science (pre-March 2025). 1/7/2022, Vol. 375 Issue 6576, p91-96. 6p. 4 Color Photographs.
Subjects: Fibrosis, Heart diseases, Antigen receptors, Nanoparticles, Lymphocytes
Abstract: Fibrosis affects millions of people with cardiac disease. We developed a therapeutic approach to generate transient antifibrotic chimeric antigen receptor (CAR) T cells in vivo by delivering modified messenger RNA (mRNA) in T cell–targeted lipid nanoparticles (LNPs). The efficacy of these in vivo–reprogrammed CAR T cells was evaluated by injecting CD5-targeted LNPs into a mouse model of heart failure. Efficient delivery of modified mRNA encoding the CAR to T lymphocytes was observed, which produced transient, effective CAR T cells in vivo. Antifibrotic CAR T cells exhibited trogocytosis and retained the target antigen as they accumulated in the spleen. Treatment with modified mRNA-targeted LNPs reduced fibrosis and restored cardiac function after injury. In vivo generation of CAR T cells may hold promise as a therapeutic platform to treat various diseases. [ABSTRACT FROM AUTHOR]
Copyright of Science (pre-March 2025) is the property of American Association for the Advancement of Science and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 154554144
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: CAR T cells produced in vivo to treat cardiac injury.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Rurik%2C+Joel+G%2E%22">Rurik, Joel G.</searchLink><br /><searchLink fieldCode="AR" term="%22Tombácz%2C+István%22">Tombácz, István</searchLink><br /><searchLink fieldCode="AR" term="%22Yadegari%2C+Amir%22">Yadegari, Amir</searchLink><br /><searchLink fieldCode="AR" term="%22Fernández%2C+Pedro+O%2E+Méndez%22">Fernández, Pedro O. Méndez</searchLink><br /><searchLink fieldCode="AR" term="%22Shewale%2C+Swapnil+V%2E%22">Shewale, Swapnil V.</searchLink><br /><searchLink fieldCode="AR" term="%22Li%2C+Li%22">Li, Li</searchLink><br /><searchLink fieldCode="AR" term="%22Kimura%2C+Toru%22">Kimura, Toru</searchLink><br /><searchLink fieldCode="AR" term="%22Soliman%2C+Ousamah+Younoss%22">Soliman, Ousamah Younoss</searchLink><br /><searchLink fieldCode="AR" term="%22Papp%2C+Tyler+E%2E%22">Papp, Tyler E.</searchLink><br /><searchLink fieldCode="AR" term="%22Tam%2C+Ying+K%2E%22">Tam, Ying K.</searchLink><br /><searchLink fieldCode="AR" term="%22Mui%2C+Barbara+L%2E%22">Mui, Barbara L.</searchLink><br /><searchLink fieldCode="AR" term="%22Albelda%2C+Steven+M%2E%22">Albelda, Steven M.</searchLink><br /><searchLink fieldCode="AR" term="%22Puré%2C+Ellen%22">Puré, Ellen</searchLink><br /><searchLink fieldCode="AR" term="%22June%2C+Carl+H%2E%22">June, Carl H.</searchLink><br /><searchLink fieldCode="AR" term="%22Aghajanian%2C+Haig%22">Aghajanian, Haig</searchLink><br /><searchLink fieldCode="AR" term="%22Weissman%2C+Drew%22">Weissman, Drew</searchLink><br /><searchLink fieldCode="AR" term="%22Parhiz%2C+Hamideh%22">Parhiz, Hamideh</searchLink><br /><searchLink fieldCode="AR" term="%22Epstein%2C+Jonathan+A%2E%22">Epstein, Jonathan A.</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Science+%28pre-March+2025%29%22">Science (pre-March 2025)</searchLink>. 1/7/2022, Vol. 375 Issue 6576, p91-96. 6p. 4 Color Photographs.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Fibrosis%22">Fibrosis</searchLink><br /><searchLink fieldCode="DE" term="%22Heart+diseases%22">Heart diseases</searchLink><br /><searchLink fieldCode="DE" term="%22Antigen+receptors%22">Antigen receptors</searchLink><br /><searchLink fieldCode="DE" term="%22Nanoparticles%22">Nanoparticles</searchLink><br /><searchLink fieldCode="DE" term="%22Lymphocytes%22">Lymphocytes</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Fibrosis affects millions of people with cardiac disease. We developed a therapeutic approach to generate transient antifibrotic chimeric antigen receptor (CAR) T cells in vivo by delivering modified messenger RNA (mRNA) in T cell–targeted lipid nanoparticles (LNPs). The efficacy of these in vivo–reprogrammed CAR T cells was evaluated by injecting CD5-targeted LNPs into a mouse model of heart failure. Efficient delivery of modified mRNA encoding the CAR to T lymphocytes was observed, which produced transient, effective CAR T cells in vivo. Antifibrotic CAR T cells exhibited trogocytosis and retained the target antigen as they accumulated in the spleen. Treatment with modified mRNA-targeted LNPs reduced fibrosis and restored cardiac function after injury. In vivo generation of CAR T cells may hold promise as a therapeutic platform to treat various diseases. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Science (pre-March 2025) is the property of American Association for the Advancement of Science and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=154554144
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1126/science.abm0594
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 6
        StartPage: 91
    Subjects:
      – SubjectFull: Fibrosis
        Type: general
      – SubjectFull: Heart diseases
        Type: general
      – SubjectFull: Antigen receptors
        Type: general
      – SubjectFull: Nanoparticles
        Type: general
      – SubjectFull: Lymphocytes
        Type: general
    Titles:
      – TitleFull: CAR T cells produced in vivo to treat cardiac injury.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rurik, Joel G.
      – PersonEntity:
          Name:
            NameFull: Tombácz, István
      – PersonEntity:
          Name:
            NameFull: Yadegari, Amir
      – PersonEntity:
          Name:
            NameFull: Fernández, Pedro O. Méndez
      – PersonEntity:
          Name:
            NameFull: Shewale, Swapnil V.
      – PersonEntity:
          Name:
            NameFull: Li, Li
      – PersonEntity:
          Name:
            NameFull: Kimura, Toru
      – PersonEntity:
          Name:
            NameFull: Soliman, Ousamah Younoss
      – PersonEntity:
          Name:
            NameFull: Papp, Tyler E.
      – PersonEntity:
          Name:
            NameFull: Tam, Ying K.
      – PersonEntity:
          Name:
            NameFull: Mui, Barbara L.
      – PersonEntity:
          Name:
            NameFull: Albelda, Steven M.
      – PersonEntity:
          Name:
            NameFull: Puré, Ellen
      – PersonEntity:
          Name:
            NameFull: June, Carl H.
      – PersonEntity:
          Name:
            NameFull: Aghajanian, Haig
      – PersonEntity:
          Name:
            NameFull: Weissman, Drew
      – PersonEntity:
          Name:
            NameFull: Parhiz, Hamideh
      – PersonEntity:
          Name:
            NameFull: Epstein, Jonathan A.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 07
              M: 01
              Text: 1/7/2022
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 00368075
          Numbering:
            – Type: volume
              Value: 375
            – Type: issue
              Value: 6576
          Titles:
            – TitleFull: Science (pre-March 2025)
              Type: main
ResultId 1